enzyme-linked immunosorbent assay
enzyme-linked immunosorbent assay is an intervention with 36 clinical trials. Currently 1 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 24 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
24 of 30 finished
20.0%
6 ended early
1
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Relationship Between Serum N/OFQ and Acute Myeloid Cell Leukemia
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Clinical Trials (36)
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Relationship Between Serum N/OFQ and Acute Myeloid Cell Leukemia
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer
Relationship Between Serum N/OFQ and Brain-heart Syndrome
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
MUC1 Vaccine for Triple-negative Breast Cancer
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 36